Publisher John Wiley & Sons, Inc., US, has announced that the Journal of Cellular and Molecular Medicine and Microbial Biotechnology have joined the Wiley Open Access publishing programme. All articles in these two journals are now open access and free to view, download and share.
Since its launch in 1996, the Journal of Cellular and Molecular Medicine has attracted very high quality submissions and attained an Impact Factor of 4.125, placing it 22nd in the Medicine Research and Experimental ISI Category. With its emphasis on translational medicine, and high quality review series, the journal is of interest to a wide spectrum of researchers and clinicians. Converting to open access allows all readers to benefit from the high-level research advances reported in the journal, driving biomedical research forward and accelerating discovery.
Since its inception, Microbial Biotechnology has published papers of original research reporting significant advances in any aspect of microbial applications to biotechnologies, making it of interest to a wide spectrum of researchers across the scope of both Microbiology and Biotechnology. It is expected that converting to open access will significantly benefit readers and researchers in the field of biotechnology, through the dissemination of high quality research from Microbial Biotechnology.
Journal of Cellular and Molecular Medicine and Microbial Biotechnology will publish all articles from January 2013 under the Creative Commons Attribution (CC-BY) License, which permits use, distribution, reproduction and adaptation in any medium, provided the original work is properly cited. A publication fee will be payable by authors or their funder on acceptance of their primary research articles. Authors affiliated with, or funded by, an organisation that has a Wiley Open Access Account can publish without directly paying any publication charges.
